Admission Date:  [**2118-6-25**]              Discharge Date:   [**2118-7-7**]   Service: MEDICINE  Allergies: Metolazone Analogues  Attending:[**First Name3 (LF) 41017**] Chief Complaint: Rectal bleeding  Major Surgical or Invasive Procedure: Blood transfusion Intubation Central line placement Upper endoscopy   History of Present Illness: This is an 81 year-old female with history of coronary artery disease status for CABG, peripheral vascular disease, diabetes, atrial fibrillation, congestive heart failure, chronic renal disease who was admitted with a GI bleed.
Type II diabetes on oral hypoglycemic agents 2.
Coronary artery disease status post CABG in [**2107**] (LIMA to LAD, SVG to OM, SVG to RCA).
Peripheral vascular disease bypass surgery bilaterally and later had below the knee amputation on the right ([**7-11**]) and stent to left bypass graft ([**3-14**]).
Anemia with baseline hematocrit 28-32.
She initially received 2L of fluid resuscitation and 2 units of red cells.
Her INR was reversed with fresh frozen plasma and vitamin K.  A nasogastric lavage was negative.
A central line was placed, and she was started on dopamine for blood pressure support.
She was started on IV protonix.
Her aspirin, plavix, and coumadin were held in the setting of her bleed.
Once she was hemodynamically stable, her aspirin and plavix were restarted.
She received a unit of red cells prior to discharge.
A decision about whether or not to restart her coumadin will be made by her primary care physician in [**Name9 (PRE) 702**].
Respiratory Failure: She was initially intubated for airway protection during unresponsiveness in setting of hypotension.
Once she was hemodynamically stable, she was treated with afterload reduction and gentle diuresis.
She was started on a course of levofloxacin and vancomycin to a complete a 10 day course.
She was weaned off ventilator support shortly after admission to the ICU.
At the time of discharge, she was oxygenating well on her usual 2L nasal cannula.
As she was not a candidate for further intervention, she was treated with medical management.
Once she was hemodynamically stable, she was restarted on her aspirin, plavix, lisinopril, and metoprolol.
Her metoprolol, lisinopril, and digoxin were held given bradycardia and renal dysfunction.
Prior to discharge, her metoprolol, lisinopril, digoxin, and lasix were restarted.
Nephrotoxic medications were intially held.
Her creatinine returned to baseline with fluid resuscitation.
All her home medications were restarted prior to discharge.
Atrial fibrillation: She was on coumadin for anticoagulation.
Her coumadin will be held until she sees her primary care physician as an outpatient.
Her nodal agents were also held initially given bradycardia.
She was transitioned to metoprolol with good rate control.
Her sugars were under good control with an insulin sliding scale.
Her glipizide was restarted prior to discharge.
FEN: She was maintained on a cardiac, diabetic diet once she was extubated.
Medications on Admission: Plavix 75mg qday protonix 40mg qday tums 500mg tid senna prn lopressor 25mg tid zyprexa 5mg qhs neurontin 300mg qhs coumadin per INR zocor 40mg qday lasix 120mg qd ASA 325 qd zestril 2.5 qhs glipizide 10 [**Hospital1 **] calcium/vitamin D zolpidem 5 qhs prn  Discharge Medications: 1.
Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Artificial Tear with Lanolin 0.1-0.1 % Ointment Sig: One (1) Appl Ophthalmic  PRN (as needed).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
Levofloxacin 250 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 3 days.
Furosemide 40 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)).
Furosemide 40 mg Tablet Sig: Two (2) Tablet PO QAM (once a day (in the morning)).
Glipizide 5 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Metoprolol Succinate 50 mg Tablet Sustained Release 24HR Sig: One (1) Tablet Sustained Release 24HR PO BID (2 times a day).
Vancomycin in Dextrose 1 g/200 mL Piggyback Sig: One (1) Intravenous  Q48H (every 48 hours) for 3 days.
Discharge Instructions: Please take all medications as prescribed and keep all follow-up appointments.
You should not take your coumadin until you see your primary care physician.
